Papers
32
Total Citations
912
H-Index
15
About
Sebastiaan Festen is a leading figure in the advancement of minimally invasive pancreatic surgery, with a research focus centered on the safety, efficacy, and implementation of laparoscopic and robotic pancreatoduodenectomy. His major contributions include leading landmark trials like the LEOPARD studies, which demonstrated the benefits of minimally invasive distal pancreatectomy, and the LEOPARD-2 trial, a pivotal randomized controlled trial comparing minimally invasive and open pancreatoduodenectomy. Festen has been instrumental in developing and validating structured training programs, notably the LAELAPS-3 multicenter initiative, which proved that safe implementation of robotic pancreatoduodenectomy is feasible across multiple centers. His work has garnered significant impact, with his most cited paper, "Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy," accumulating over 159 citations. He has also published influential studies on conversion risks and learning curves, including an analysis of 635 robotic procedures. Through his rigorous, evidence-based approach, Festen has helped shape global standards for minimally invasive pancreatic surgery, making complex procedures safer and more accessible for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy159 citations · 2018
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10